Gemcitabine is known to activate various protein kinases such as ERK (34), AKT (25,34), EGFR and HER3 (34) in pancreatic cancer cells, and PKC (35) in ovarian cancer cells. Here, PRRT2 is linked to ovarian carcinoma.